UA78526C2 - Antibody against caspase-8, a process for preparation and use of said antibody for development of elisa-analysis - Google Patents

Antibody against caspase-8, a process for preparation and use of said antibody for development of elisa-analysis Download PDF

Info

Publication number: UA78526C2
Authority: UA; Ukraine
Prior art keywords: caspase; antibody; peptide; antibodies; protein
Prior art date: 2001-09-04

Application number

UA2004042509A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-04

Filing date

2002-04-09

Publication date

2007-04-10

2002-04-09 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2007-04-10 Publication of UA78526C2 publication Critical patent/UA78526C2/uk

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Hematology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

UA2004042509A 2001-09-04 2002-04-09 Antibody against caspase-8, a process for preparation and use of said antibody for development of elisa-analysis UA78526C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL14527901A IL145279A0 (en)	2001-09-04	2001-09-04	Antibodies against caspase-8, their preparation and use
PCT/IL2002/000734 WO2003020767A2 (en)	2001-09-04	2002-09-04	Antibodies against caspase-8, their preparation and use

Publications (1)

Publication Number	Publication Date
UA78526C2 true UA78526C2 (en)	2007-04-10

Family

ID=11075764

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2004042509A UA78526C2 (en)	2001-09-04	2002-04-09	Antibody against caspase-8, a process for preparation and use of said antibody for development of elisa-analysis

Country Status (18)

Country	Link
US (2)	US20050058648A1 (de)
EP (2)	EP1423429B1 (de)
JP (1)	JP2005501905A (de)
KR (1)	KR20040044535A (de)
CN (1)	CN1599755A (de)
AT (1)	ATE335766T1 (de)
BR (1)	BR0212289A (de)
CA (1)	CA2458985A1 (de)
CY (1)	CY1106200T1 (de)
DE (1)	DE60213827T2 (de)
DK (1)	DK1423429T3 (de)
EA (1)	EA009770B1 (de)
ES (1)	ES2265511T3 (de)
IL (1)	IL145279A0 (de)
MX (1)	MXPA04002104A (de)
PT (1)	PT1423429E (de)
UA (1)	UA78526C2 (de)
WO (1)	WO2003020767A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL158599A0 (en) *	2003-10-26	2004-05-12	Yeda Res & Dev	Methods of modulating hematopoiesis
US7838645B2 (en) *	2004-04-30	2010-11-23	University Of Maryland College Park	Function of autophagy genes in cell death
EP2492281B1 (de) *	2009-10-19	2018-04-11	HanAll Biopharma Co., Ltd.	Modifiziertes menschliches tumornekrose-faktor-rezeptor-1-polypeptid oder fragment davon sowie herstellungsverfahren dafür
CN106146665B (zh) *	2016-08-31	2019-08-09	中国农业科学院植物保护研究所	一种用于制备针对甜菜夜蛾caspase-5大亚基的抗体的方法
CN112255061A (zh) *	2020-10-13	2021-01-22	南开大学	一种通过免疫沉淀分离和检测蛋白质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
AU5544500A (en) *	1999-06-15	2001-01-02	Astrazeneca Ab	Livin; inhibitor-of-apoptosis protein-3 (iap-3)
FR2878852B1 (fr) *	2000-09-28	2007-02-23	Imtix Sangstat	Procede de production d'immunoglobulines anti-thymocytes humains

2001
- 2001-09-04 IL IL14527901A patent/IL145279A0/xx unknown
2002
- 2002-04-09 UA UA2004042509A patent/UA78526C2/uk unknown
- 2002-09-04 JP JP2003525037A patent/JP2005501905A/ja active Pending
- 2002-09-04 EP EP02762749A patent/EP1423429B1/de not_active Expired - Lifetime
- 2002-09-04 DK DK02762749T patent/DK1423429T3/da active
- 2002-09-04 KR KR10-2004-7003217A patent/KR20040044535A/ko not_active Ceased
- 2002-09-04 DE DE60213827T patent/DE60213827T2/de not_active Expired - Fee Related
- 2002-09-04 PT PT02762749T patent/PT1423429E/pt unknown
- 2002-09-04 MX MXPA04002104A patent/MXPA04002104A/es active IP Right Grant
- 2002-09-04 EA EA200400393A patent/EA009770B1/ru not_active IP Right Cessation
- 2002-09-04 AT AT02762749T patent/ATE335766T1/de not_active IP Right Cessation
- 2002-09-04 CN CNA028219678A patent/CN1599755A/zh active Pending
- 2002-09-04 CA CA002458985A patent/CA2458985A1/en not_active Abandoned
- 2002-09-04 WO PCT/IL2002/000734 patent/WO2003020767A2/en not_active Ceased
- 2002-09-04 ES ES02762749T patent/ES2265511T3/es not_active Expired - Lifetime
- 2002-09-04 BR BR0212289-8A patent/BR0212289A/pt not_active IP Right Cessation
- 2002-09-04 EP EP06014417A patent/EP1770101A1/de not_active Withdrawn
- 2002-09-04 US US10/488,608 patent/US20050058648A1/en not_active Abandoned
2006
- 2006-10-16 CY CY20061101481T patent/CY1106200T1/el unknown
2007
- 2007-05-08 US US11/745,949 patent/US20080311599A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2005501905A (ja)	2005-01-20
IL145279A0 (en)	2002-06-30
DE60213827D1 (de)	2006-09-21
EA009770B1 (ru)	2008-04-28
DK1423429T3 (da)	2006-09-04
MXPA04002104A (es)	2004-06-07
CN1599755A (zh)	2005-03-23
WO2003020767A2 (en)	2003-03-13
ES2265511T3 (es)	2007-02-16
PT1423429E (pt)	2006-12-29
WO2003020767A3 (en)	2003-10-02
EP1770101A1 (de)	2007-04-04
DE60213827T2 (de)	2007-03-29
ATE335766T1 (de)	2006-09-15
CY1106200T1 (el)	2011-06-08
WO2003020767A9 (en)	2004-04-15
CA2458985A1 (en)	2003-03-13
EP1423429A2 (de)	2004-06-02
US20050058648A1 (en)	2005-03-17
EA200400393A1 (ru)	2004-08-26
US20080311599A1 (en)	2008-12-18
BR0212289A (pt)	2004-09-14
EP1423429B1 (de)	2006-08-09
KR20040044535A (ko)	2004-05-28

Similar Documents

Publication	Publication Date	Title
US8846047B2 (en)	2014-09-30	Monoclonal antibodies against HMGB1
TWI264467B (en)	2006-10-21	Human anti-CD40 antibodies and methods of making and using same
JP4382827B2 (ja)	2009-12-16	Ａ−３３関連抗原およびそれらの薬理学的使用
NO327240B1 (no)	2009-05-18	Interleukin-18-bindende protein, DNA som koder for dette, vektor og celle inneholdende slikt DNA, fremgangsmate for fremstilling av proteinet, antistoffer som reagerer mot proteinet samt anvendelse av proteinet for fremstilling av medikamenter.
EP2168599B1 (de)	2016-08-10	Krebsheilmittel mit einem antikörper gegen ein vom exon-17-bereich von periostin kodiertes peptid
US7018839B2 (en)	2006-03-28	Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
US5891437A (en)	1999-04-06	Antigen associated with type I diabetes mellitus
KR101154550B1 (ko)	2012-06-08	폰 빌레브란트 인자 특이적 절단 효소에 대한 항체 및그것을 이용한 분석계
US20080311599A1 (en)	2008-12-18	Antibodies against caspase-8, their preparation and use
EA009956B1 (ru)	2008-04-28	Внутриклеточный полипептид (cari) и способы его применения
US7544481B1 (en)	2009-06-09	Nucleic acids encoding CD40 binding protein
WO2004031241A1 (ja)	2004-04-15	ズブチリシン様プロプロテインコンベルターゼ・ｐａｃｅ４に対するモノクローナル抗体及びその利用
AU2002328090A1 (en)	2003-03-18	Antibodies against caspase-8, their preparation and use
JP2004141161A (ja)	2004-05-20	ズブチリシン様プロプロテインコンベルターゼ・ｐａｃｅ４に対するモノクローナル抗体及びその利用
UA76081C2 (en)	2006-07-17	Dna sequence coding rip-associated protein (rap-2), competent to replication, expressing vector, transformed host cell, protein rap-2, a method for obtaining thereof, antibody, pharmaceutical composition and methods for modelling of modulated or mediated by protein rip influence on cells
JP2000253881A (ja)	2000-09-19	ヒトキャスペース−３（Ｃａｓｐａｓｅ−３）活性誘導物質及びヒトキャスペース−３（Ｃａｓｐａｓｅ−３）活性調節物質